ProVise Management Group’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-563
| Closed | -$348K | – | 290 |
|
|
2024
Q3 | $348K | Buy |
563
+163
| +41% | +$101K | 0.03% | 231 |
|
|
2024
Q2 | $221K | Hold |
400
| – | – | 0.02% | 271 |
|
|
2024
Q1 | $232K | Sell |
400
-8
| -2% | -$4.65K | 0.02% | 266 |
|
|
2023
Q4 | $217K | Hold |
408
| – | – | 0.02% | 313 |
|
|
2023
Q3 | $207K | Hold |
408
| – | – | 0.02% | 314 |
|
|
2023
Q2 | $213K | Hold |
408
| – | – | 0.02% | 321 |
|
|
2023
Q1 | $235K | Hold |
408
| – | – | 0.02% | 308 |
|
|
2022
Q4 | $225K | Hold |
408
| – | – | 0.02% | 291 |
|
|
2022
Q3 | $207K | Sell |
408
-47
| -10% | -$23.8K | 0.02% | 293 |
|
|
2022
Q2 | $247K | Buy |
455
+59
| +15% | +$32K | 0.03% | 287 |
|
|
2022
Q1 | $234K | Buy |
396
+1
| +0.3% | +$591 | 0.02% | 330 |
|
|
2021
Q4 | $264K | Hold |
395
| – | – | 0.02% | 328 |
|
|
2021
Q3 | $226K | Sell |
395
-10
| -2% | -$5.72K | 0.02% | 337 |
|
|
2021
Q2 | $204K | Buy |
+405
| New | +$204K | 0.02% | 367 |
|
|
2019
Q1 | – | Sell |
-1,004
| Closed | -$225K | – | 322 |
|
|
2018
Q4 | $225K | Buy |
+1,004
| New | +$225K | 0.04% | 263 |
|